NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed May 19, 2017
Insider Transaction Report
Form 4
Latkin Jed
DirectorCEO, COO & CFO
Transactions
- Award
Common Stock, $.001 par value
2017-05-17$0.47/sh+13,300$6,211→ 13,300 total - Award
Common Stock, $.001 par value
2017-05-18$0.45/sh+3,900$1,753→ 17,200 total
Signature
/s/ Jed A. Latkin|2017-05-19